🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 04216R102 (prev. 03211P202 )
- Market Cap
- Small Cap
- Previous Symbol
- APHB (changed 5/9/2019)
- Previous Name
- AmpliPhi Biosciences Corp.
Business: Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology.
Notes: May 9, 2019 -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the previously-announced merger between C3J Therapeutics, Inc. ("C3J") and AmpliPhi Biosciences Corporation (NYSE American: APHB) ("AmpliPhi") has closed. The new combined company, known as Armata Pharmaceuticals, Inc., will focus on the development and advancement of phage-based therapeutic candidates to treat antibiotic-resistant infections.
Company Contact
- CEO
- Deborah Birx
- CFO
- David House
- Headquarters
- 4503 Glencoe Avenue, Marina del Rey, CA 90292
- Phone
- 310-665-2928
- Investor Relations
- Joyce Allaire, LifeSci Advisors, LLC · 212-915-2569 · jallaire@lifesciadvisors.com